RespireRx Pharmaceuticals Market Cap

RespireRx Pharmaceuticals has a market cap or net worth of $2.28 million as of January 31, 2025. Its market cap has increased by 702.94% in one year.

Market Cap

2.28M

Enterprise Value

5.86M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since May 1, 1992, RespireRx Pharmaceuticals's market cap has decreased from 26.39M to 2.28M, a decrease of -91.36%. That is a compound annual growth rate of -7.20%.

Market Cap History

Date	Market Cap	% Change
Jan 31, 2025	2.28M	200.00%
Dec 31, 2024	759.57K	65.58%
Dec 29, 2023	458.74K	58.87%
Dec 30, 2022	288.75K	-74.38%
Dec 31, 2021	1.13M	-45.46%
Dec 31, 2020	2.07M	411.01%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	2.10B
SS Innovations International	1.55B
Veradigm	1.36B
Nika Pharmaceuticals	1.02B
Elite Pharmaceuticals	500.05M
Glass House Brands	467.54M
Northwest Biotherapeutics	377.51M
BioStem Technologies	254.31M

Market Cap Rankings